Protective effect of the insulin-like growth factor I receptor on apoptosis induced by okadaic acid

Cancer Research

Volumn 57, Issue 15, 1997, Pages 3264-3271

  D'Ambrosio, Consuelo ^a,c   Valentinis, Barbara ^a   Prisco, Marco ^a   Reiss, Krzysztof ^a   Rubini, Michele ^b   Baserga, Renato ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b UNIVERSITY OF FERRARA   (Italy)

^c UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 3; OKADAIC ACID; SOMATOMEDIN C RECEPTOR;

AMINO ACID SEQUENCE; APOPTOSIS; ARTICLE; CELL LINE; ENZYME ACTIVITY; MITOGENESIS; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RECEPTOR BINDING;

ANIMALS; APOPTOSIS; CELL CYCLE; CELL LINE; DOSE-RESPONSE RELATIONSHIP, DRUG; FIBROBLASTS; MICE; OKADAIC ACID; PHOSPHOPROTEINS; PHOSPHORYLATION; RECEPTORS, SOMATOMEDIN;

EID: 0030854846     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. McCubrey, J. A., Stillman, L. S., Mayhew, M. W., Algate, P. A., Dellow, R. A., and Kaleko, M. Growth promoting effects of insulin-like growth factor 1 (IGF-1) on hematopoietic cells: overexpression of introduced IGF-1 receptor abrogates interleukin-3 dependency of murine factor dependent cells by ligand dependent mechanism. Blood, 78: 921-929, 1991.
2. Rodriguez-Tarduchy, G., Collins, M. K. L., Garcia, I., and Lopez-Rivas, A. Insulin-like growth factor I inhibits apoptosis in IL-3 dependent hemopoietic cells. J. Immunol., 149: 535-540, 1992.
3. Harrington, E. A., Bennett, M. R., Fanidi, A., and Evan, G. I. c-myc-induced apoptosis in fibroblasts is inhibited by specific cytokines. EMBO J., 13: 3286-3295, 1994.
4. Parrizas, M., Saltiel, A. R., and LeRoith, D. Insulin-like growth factor I inhibits apoptosis using the phosphatidylinositol 3′-kinase and mitogen-activated protein kinase pathways. J. Biol. Chem., 272: 154-161, 1997.
5. Jung, Y. K., Miura, M., and Yuan, J. Suppression of interleukin-1β converting enzyme-mediated cell death by insulin-like growth factor. J. Biol. Chem., 271: 5112-5117, 1996.
6. Singleton, J. R., Randolph, A. E., and Feldman, E. L. Insulin-like growth factor I receptor prevents apoptosis and enhances neuroblastoma tumorigenesis. Cancer Res., 56: 4522-4529, 1996.
7. Sell, C., Baserga, R., and Rubin, R. Insulin-like growth factor I (IGF-I) and the IGF-I receptor prevent etoposide-induced apoptosis. Cancer Res., 55: 303-306, 1995.
8. Valentinis, B., and Baserga, R. The IGF-I receptor protects tumor cells from apoptosis induced by high concentrations of serum. Biochem. Biophys. Res. Commun., 224: 362-368, 1996.
9. Wu, Y., Tewari, M., Cui, S., and Rubin, R. Activation of the insulin-like growth factor I receptor inhibits tumor necrosis factor-induced cell death. J. Cell. Physiol., 168: 499-509, 1996.
10. O'Connor, R., Kauffmann-Zeh, A., Liu, Y., Lehar, S. Evan, G. I., Baserga, R., and Blattler, W. A. The IGF-I receptor domains for protection from apoptosis are distinct from those required for proliferation and transformation. Mol. Cell. Biol., 17: 427-435, 1997.
11. Resnicoff, M., Abraham, D., Yutanawiboonchai, W., Rotman, H., Kajstura, J., Rubin, R., Zoltick, P., and Baserga, R. The insulin-like growth factor I receptor protects tumor cells from apoptosis in vivo. Cancer Res., 55: 2463-2469, 1995.
12. Resnicoff, M., Burgaud, J-L., Rotman, H. L., Abraham, D., and Baserga, R. Correlation between apoptosis, tumorigenesis, and levels of insulin-like growth factor I receptors. Cancer Res., 55: 3739-3741, 1995.
13. D'Ambrosio, C., Ferber, A., Resnicoff, M., and Baserga, R. A soluble insulin-like growth factor I receptor that induces apoptosis of tumor cells in vivo and inhibits tumorigenesis. Cancer Res., 56: 4013-4020, 1996.
14. Werner, H., Karnieli, E., Rauscher, F. J., III, and LeRoith, D. Wild type and mutant p53 differentially regulate transcription of insulin-like growth factor I receptor gene. Proc. Natl. Acad. Sci. USA, 93: 8318-8323, 1996.
15. Buckbinder, L., Talbott, R., Velasco-Miguel, S., Takenaka, I., Faha, B., Seizinger, B. R., and Kley, N. Induction of the growth inhibitor IGF-binding protein 3 by p53. Nature (Lond.), 377: 646-649, 1995.
16. Prisco, M., Hongo, A., Rizzo, M. G., Sacchi, A., and Baserga, R. The IGF-I receptor as a physiologically relevant target of p53 in apoptosis caused by interleukin-3 withdrawal. Mol. Cell. Biol., 17: 1084-1092, 1997.
17. Cohen, P., Holmes, C. F. B., and Tsukitani, Y. Okadaic acid: a new probe for the study of cellular regulation. Trends Biochem. Sci., 15: 98-102, 1990.
18. Afshari, C. A., Bivins, H. M., and Barrett, J. C. Utilization of a fos-lacZ plasmid to investigate the activation of c-fos during cellular senescence and okadaic acid-induced apoptosis. J. Gerontol., 29: B263-B269, 1994.
19. Haldar, S., Jena, N., and Croce, C. M. Antiapoptosis potential of bcl-2 oncogene in dephosphorylation. Biochem. Cell Biol., 72: 455-462, 1994.
20. Haldar, S., Jena, N., and Croce, C. Inactivation of Bcl-2 by phosphorylation. Proc. Natl. Acad. Sci. USA, 92: 4507-4511, 1995.
21. Kawamura, K. I., Grabowski, D., Weizer, K., Bukowski, R., and Ganapathi, R. Modulation of vinblastine cytotoxicity by dilantin (phenytoin) or the protein phosphatase inhibitor okadaic acid involves the potentiation of anti-mitotic effects and induction of apoptosis in human tumour cells. Br. J. Cancer, 73: 183-188, 1996.
22. Sheikh, M. S., Garcia, M., Zhan, Q., Liu, Y., and Fomace, A. J., Jr. Cell cycle-independent regulation of p21/Waf1/Cip1 and retinoblastoma protein during okadaic acid-induced apoptosis is coupled with induction of Bax protein in human breast carcinoma cells. Cell Growth & Differ., 7: 1599-1607, 1996.